峆一药业
(920478)
| 流通市值：7.45亿 | | | 总市值：12.25亿 |
| 流通股本：6700.42万 | | | 总股本：1.10亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 76,006,054.25 | 46,166,565.25 | 287,684,655.66 | 210,767,634.24 |
| 营业总成本 | 83,293,516.92 | 45,849,960.29 | 235,640,884.72 | 165,268,778.91 |
| 其他经营收益 | | | | |
| 营业利润 | -2,737,450.64 | 2,319,064.04 | 53,967,715.61 | 50,557,208.52 |
| 利润总额 | -5,715,069.59 | 2,336,545.95 | 53,674,359.42 | 50,494,719.69 |
| 净利润 | -6,155,194.4 | 1,667,015.12 | 44,645,913.6 | 43,156,004.51 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -6,155,194.4 | 1,667,015.12 | 44,645,913.6 | 43,156,004.51 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 298,796,462.86 | 311,617,391.68 | 334,615,325.69 | 326,524,271.59 |
| 非流动资产: | | | | |
| 非流动资产合计 | 343,501,450.59 | 336,277,578.9 | 302,638,720.55 | 290,215,794.08 |
| 资产总计 | 642,297,913.45 | 647,894,970.58 | 637,254,046.24 | 616,740,065.67 |
| 流动负债: | | | | |
| 流动负债合计 | 60,809,443.33 | 61,793,325.85 | 74,895,427.91 | 66,932,473.16 |
| 非流动负债: | | | | |
| 非流动负债合计 | 74,587,709.05 | 62,541,429.13 | 38,262,355.9 | 30,564,394.32 |
| 负债合计 | 135,397,152.38 | 124,334,754.98 | 113,157,783.81 | 97,496,867.48 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 504,693,431.98 | 519,283,254.57 | 518,264,816.52 | 510,683,078.47 |
| 股东权益合计 | 506,900,761.07 | 523,560,215.6 | 524,096,262.43 | 519,243,198.19 |
| 负债和股东权益合计 | 642,297,913.45 | 647,894,970.58 | 637,254,046.24 | 616,740,065.67 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 103,568,141.83 | 68,732,723.74 | 295,353,922.86 | 266,471,256.46 |
| 经营活动现金流出小计 | 115,631,156.51 | 58,282,375.58 | 219,788,426.3 | 199,824,143.32 |
| 经营活动产生的现金流量净额 | -12,063,014.68 | 10,450,348.16 | 75,565,496.56 | 66,647,113.14 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 340,747,726.95 | 83,629,706.11 | 436,896,818.24 | 372,933,455.11 |
| 投资活动现金流出小计 | 388,444,967.28 | 174,160,058 | 496,727,772.26 | 426,742,987.46 |
| 投资活动产生的现金流量净额 | -47,697,240.33 | -90,530,351.89 | -59,830,954.02 | -53,809,532.35 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 38,434,973.01 | 24,324,193.7 | 37,461,814.89 | 29,774,114.89 |
| 筹资活动现金流出小计 | 12,287,102.74 | 2,273,942.06 | 29,000,718.71 | 28,784,966.48 |
| 筹资活动产生的现金流量净额 | 26,147,870.27 | 22,050,251.64 | 8,461,096.18 | 989,148.41 |
| 汇率变动对现金及现金等价物的影响 | -833,093.61 | 71,360.43 | 1,135,331.73 | 1,146,003.42 |
| 现金及现金等价物净增加额 | -34,445,478.35 | -57,958,391.66 | 25,330,970.45 | 14,972,732.62 |
| 期末现金及现金等价物余额 | 60,589,030.79 | 37,076,117.48 | 95,034,509.14 | 84,676,271.31 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -34,445,478.35 | - | 25,330,970.45 | - |